De Novo Lipogenesis in Myocardial Dysfunction
心肌功能障碍中的从头脂肪生成
基本信息
- 批准号:8469343
- 负责人:
- 金额:$ 11.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-15 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAdvisory CommitteesBasic ScienceBiological SciencesCalciumCardiacCardiac OutputCardiologyCardiovascular systemCell Culture TechniquesCell physiologyClinicalClinical SciencesDataDevelopment PlansDoctor of PhilosophyEnzymesFacultyFatty AcidsFatty-acid synthaseFunctional disorderFutureGoalsHeartHypothalamic structureIn VitroIndividualInfarctionInternal MedicineIon ChannelIschemiaKnock-outLaboratoriesLinkLipidsLiverMass Spectrum AnalysisMedicineMentorshipMetabolismMitochondriaModelingModificationMusMyocardialMyocardial IschemiaMyocardial dysfunctionMyocardiumPhenotypePhysiciansPhysiologicalPhysiologyPlayPost-Translational Protein ProcessingPrincipal InvestigatorProcessProductionProteinsReperfusion TherapyResearchResourcesRoleScienceScientistSignal TransductionSourceStagingStimulusSystemTechniquesTestingThinkingTimeTissuesTrainingUniversitiesWashingtonWorkabstractingacute stresscareercareer developmentclayfascinateforgettingin vivoinsightinterestlipid biosynthesislipid mediatornovelpressurepublic health relevanceresearch studyscreeningskillstool
项目摘要
DESCRIPTION (provided by applicant): Project Summary / Abstract: This proposal aims to develop the applicant into an independent physician-scientist in the field of cardiovascular medicine. The principal investigator (PI) has already undergone PhD training in the basic biological sciences and completed clinical training in internal medicine and the cardiology subspecialty. The proposed 5-year career development plan will provide refinement of the PI's scientific skills under the mentorship of Dr. Clay Semenkovich. Dr. Semenkovich is a recognized leader in physiology and metabolism and has a track record for training successful physician-scientists, especially at the incipient stages of their careers. In addition, the PI will be able to take advantage of the enormous breadth of clinical and basic science resources available at Washington University, including obtaining scientific as well as career guidance from his faculty advisory committee and collaborators. The research set forth herein seeks to delineate the unique roles de novo lipogenesis play in myocardial physiology and pathophysiology. In the past few years, the Semenkovich laboratory has advanced our thinking about metabolism by successfully generating and characterizing mice with tissue-specific deletion of fatty acid synthase (FAS). This system enables one to study myocardial function in the absence of de novo-generated lipids, a situation that has never before been possible. We propose to test the hypothesis that FAS acts to generate lipids distinct from those obtainable from the periphery and that these lipids provide critical signaling roles under both homeostatic and acute stress conditions. We plan to address this hypothesis by characterizing FASKard (FAS Knockout in the Myocardium) mice.
描述(由申请人提供):项目摘要/摘要:本提案旨在将申请人发展成为心血管医学领域的独立医生-科学家。主要研究者(PI)已经接受了基础生物科学的博士培训,并完成了内科和心脏病学专科的临床培训。拟议的5年职业发展计划将在Clay Semenkovich博士的指导下完善PI的科学技能。Semenkovich博士是生理学和新陈代谢领域公认的领导者,在培养成功的医生科学家方面有着良好的记录,特别是在他们职业生涯的初期阶段。此外,PI将能够利用华盛顿大学提供的广泛的临床和基础科学资源,包括从他的教师咨询委员会和合作者那里获得科学和职业指导。 本文所述的研究旨在描述新生脂肪生成在心肌生理学和病理生理学中的独特作用。在过去的几年里,Semenkovich实验室通过成功地产生和表征脂肪酸合酶(FAS)组织特异性缺失的小鼠,推进了我们对代谢的思考。该系统使人们能够在没有新生脂质的情况下研究心肌功能,这种情况以前从未发生过。我们建议测试的假设,FAS的行为,以产生脂质不同的那些可从周边和这些脂质提供关键的信号作用下的稳态和急性应激条件。我们计划通过表征FASKard(肌内FAS敲除)小鼠来解决这一假设。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Babak Razani其他文献
Babak Razani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Babak Razani', 18)}}的其他基金
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis
利用巨噬细胞自噬-溶酶体生物发生反应治疗动脉粥样硬化
- 批准号:
10370137 - 财政年份:2018
- 资助金额:
$ 11.78万 - 项目类别:
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis
利用巨噬细胞自噬-溶酶体生物发生反应治疗动脉粥样硬化
- 批准号:
10549729 - 财政年份:2018
- 资助金额:
$ 11.78万 - 项目类别:
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis
利用巨噬细胞自噬-溶酶体生物发生反应治疗动脉粥样硬化
- 批准号:
10265332 - 财政年份:2018
- 资助金额:
$ 11.78万 - 项目类别:
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis
清除富含 p62 的巨噬细胞蛋白聚集体作为动脉粥样硬化的治疗方法
- 批准号:
10732859 - 财政年份:2014
- 资助金额:
$ 11.78万 - 项目类别:
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis
清除富含 p62 的巨噬细胞蛋白聚集体作为动脉粥样硬化的治疗方法
- 批准号:
10214664 - 财政年份:2014
- 资助金额:
$ 11.78万 - 项目类别:
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis
清除富含 p62 的巨噬细胞蛋白聚集体作为动脉粥样硬化的治疗方法
- 批准号:
10428518 - 财政年份:2014
- 资助金额:
$ 11.78万 - 项目类别:
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS
巨噬细胞溶酶体生物发生在动脉粥样硬化中的作用
- 批准号:
8801613 - 财政年份:2014
- 资助金额:
$ 11.78万 - 项目类别:
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS
巨噬细胞溶酶体生物发生在动脉粥样硬化中的作用
- 批准号:
8962169 - 财政年份:2014
- 资助金额:
$ 11.78万 - 项目类别:
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis
清除富含 p62 的巨噬细胞蛋白聚集体作为动脉粥样硬化的治疗方法
- 批准号:
10649536 - 财政年份:2014
- 资助金额:
$ 11.78万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 11.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 11.78万 - 项目类别:
Standard Grant